Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. - Wikidata - wikimedia - TriplyDB

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

http://www.wikidata.org/entity/Q40213284

about

Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation c-FOS suppresses ovarian cancer progression by changing adhesion Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.CpG-methylation regulates a class of Epstein-Barr virus promoters.Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.Viral response to chemotherapy in endemic burkitt lymphoma Noise cancellation: viral fine tuning of the cellular environment for its own genome replication.The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Tegument protein control of latent herpesvirus establishment and animation.Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis RNAs in Epstein-Barr virions control early steps of infection.Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination.Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology.Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.Switching of EBV cycles between latent and lytic states.Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.Modes of infection and oncogenesis by the Epstein-Barr virus.Regulation of Epstein-Barr virus reactivation from latency.Epstein-Barr virus: more than 50 years old and still providing surprises.Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification.Recent advances in understanding Epstein-Barr virus.Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.Epigenetic control of Epstein-Barr virus transcription - relevance to viral life cycle?Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?

P2860

Q26863256-FD29479D-F745-4180-9DA4-66DC791C749C Q30570979-E2E3D31C-AE74-4059-8F20-44DE5AF5891F Q30844939-9EC14C69-4CC1-4AF4-826F-3E108A9E406A Q31117844-7B791D72-E69D-4F70-918F-2F7C0DE6E5CC Q33489621-FB3E2CE0-98F0-40D6-9B4D-747CA7D683AB Q33640163-57B30EA9-ED5C-4270-8BD5-D35FCCE0D1E5 Q33680515-EEFEEF42-AAA2-49DF-9FE0-874E0AE30A0E Q33707736-9DE21589-F4BA-4D51-9E31-23D8DCE8D09E Q33760239-7F0C0DBC-5E2E-4A47-935A-1CE08A65DF84 Q33767066-FEA364CC-2B6B-4080-9AF2-22297FEB1F85 Q33780955-E1CD018C-8787-432F-886F-827B5B1A6742 Q34277034-EEE6B47D-1F08-4756-8D32-CDA44191D496 Q34520470-72414292-D8C1-4818-BE6B-30DA5E2A4851 Q34703035-E1F53A65-5C7E-4499-94AE-2944FB49B5CA Q34712750-523D4F9F-D1BC-4E1A-AFE0-2BDC5A5FA134 Q34937562-59B70307-2979-47ED-AC25-15AAB4EDFF8D Q35076733-6CF141A0-7162-4619-8959-1847DB4BCB4E Q35111065-C0B95D2B-97EA-4A43-9944-5F29A8992623 Q35581465-7CA66567-8A31-4946-B737-37FBE9858C9F Q35991530-A7B9983C-18E4-4B04-987C-4DF3438F11D3 Q35994831-0F5ACBB6-0D2C-4746-8318-188659D6A021 Q37272108-4B7C0799-CDC6-44DB-AD23-75A7028A5715 Q37272142-9E99B001-016C-4A60-AFE5-FA12E864A4E0 Q38101668-9084BEA2-FADE-4D16-A15A-C2BCE0036B19 Q38156888-1BE8FA1B-E05D-4BDA-84D3-80257AC921EA Q38171455-460D224B-507A-4CB7-8C06-BBD2A7BA13A3 Q38174306-BB1BC029-A15F-4812-B1D0-C3F25810999A Q38191876-68E1FB69-7BA0-49AD-8EB7-CAFAACCB6979 Q38208532-2FC349DC-B4EA-4EB9-9082-E47423258980 Q38968588-7EB67BB2-38B5-431E-BD40-BB9ED5166A11 Q39042093-67800095-9A36-4941-9B8C-E3A40C046E4D Q39241944-79392E10-083F-4621-BBF6-509A77BE1DDD Q39343112-EAE7CFBA-99BA-4D1B-8570-80584BB9A509 Q39392105-327752ED-8AC1-413B-9256-255BC0700EF9 Q39411850-38E32FB6-B613-471A-8553-0EE049CE34A3 Q39652746-AACDBDBB-C0D8-4478-B053-70EA5257FBCE Q40114569-7107F74C-66E5-470C-82A1-6CC22C3C9A10 Q42019706-FDD65FBC-5F6B-4C38-8183-51A289F32D6F Q42273489-06DE3FE8-66DF-4749-915E-943AA32984B4 Q45323590-8A864649-A3C9-49B3-8FBA-3BB2D034C8B3

P2860

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

http://www.wikidata.org/entity/Q40213284

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Epstein-Barr virus BZLF1 gene, ...... ry infection of B lymphocytes.

@en

type

label

Epstein-Barr virus BZLF1 gene, ...... ry infection of B lymphocytes.

@en

prefLabel

Epstein-Barr virus BZLF1 gene, ...... ry infection of B lymphocytes.

@en

P1433

Q40213284-7E658AE7-9031-4E6E-86FB-F34A0215162A

P1476

Q40213284-999846DA-4443-4E85-8904-E7A6B13DE22A

P2093

Q40213284-2D9566EA-47A6-443C-85C9-210BE271022D

Q40213284-3895F336-DADF-4FC3-A6FD-CEB8A5997F56

Q40213284-7951196B-5369-42EF-997A-BD0899E86FEF

Q40213284-A8E2E3E8-EBC3-4421-9203-593053AD83FF

Q40213284-EEA11DC4-7ECB-4974-A869-6E6536DC619E

Q40213284-FC25E302-A843-495E-837E-3ACA78B497CA

P2860

Q40213284-00FE8BC4-23A9-494C-B891-C3E150004F62

Q40213284-093102E5-C566-402D-A9C1-1AA7491E10E8

Q40213284-0FABCEE5-436F-43AD-822B-036CF7B268B0

Q40213284-27FF251C-CB6C-4BCD-B4FF-28565305F041

Q40213284-2944F5C8-298B-48EB-9383-EA6D2969C591

Q40213284-37DEDAFD-7E83-4B2D-8A6A-CFC1E7B3C481

Q40213284-4153086F-76A9-4BD9-8B79-21AFCC10A2A5

Q40213284-446BB4CC-4A64-43A8-8FBB-CFDBDF9424DD

Q40213284-44D36194-8DCF-4B03-8CB1-71B0969E06FF

Q40213284-5106503B-D77C-4D6E-BFE3-C0B9E0EE7586

P304

Q40213284-3E1E324F-FC8C-4FE9-99BE-C118B5A709A9

P31

Q40213284-A077D667-E9A5-4EB3-8A20-FB9ED354532D

P356

Q40213284-9E2F5CD3-AE92-496E-A7BD-3E377A6C49FD

P407

Q40213284-2344A832-B40E-4B59-BBE1-3D78D0972635

P433

Q40213284-A128CF36-41CE-46A1-B690-36ABD7436DDB

P478

Q40213284-D1FD540F-4558-4FDB-91D6-02A6815121BB

P577

Q40213284-9BF97C5D-8A6B-4CCD-9407-B4D75DDFA3F2

P698

Q40213284-AFABCD64-9B6D-4BCB-9392-851336E82203

P921

Q40213284-E0F6D3F2-14BF-4C8A-AA18-43FB7037CA81

P932

Q40213284-0A7739E8-ACD2-4FAB-85A0-4DD7BFEEE50D

P356

P1433

Journal of Virology

P1476

Epstein-Barr virus BZLF1 gene, ...... ry infection of B lymphocytes.

@en

P2093

Dai Iwakiri

http://www.w3.org/2001/XMLSchema#string

Kenzo Takada

http://www.w3.org/2001/XMLSchema#string

Koji Yamamoto

http://www.w3.org/2001/XMLSchema#string

Seiji Maruo

http://www.w3.org/2001/XMLSchema#string

Teru Kanda

http://www.w3.org/2001/XMLSchema#string

Wangrong Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.

The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity

The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.

Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos.

Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.

Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1

Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

P304

1037-1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01416-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17079287

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

1797481

http://www.w3.org/2001/XMLSchema#string